Evidence map›Paper›PMID 34732703›Full record

ArticleNature communications2021

Convergence of oncogenic cooperation at single-cell and single-gene levels drives leukemic transformation.

Yuxuan Liu, Zhimin Gu, Hui Cao, Pranita Kaphle, Junhua Lyu, Yuannyu Zhang, Wenhuo Hu, Stephen S Chung, Kathryn E Dickerson, Jian Xu

Open access · goldAbstract read
In one paragraph

Article in Nature communications, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
1.1field-weighted citation impact, top 23% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 16 citations in OpenAlex.

  1. A Darwinian Perspective on Tumor Evolution.International journal of biological sciences · 2026
    Review
  2. Article
  3. diffGEK: differential gene expression kinetics.Bioinformatics (Oxford, England) · 2025
    Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 3 institutions in 1 country.

Yuxuan Liu *Children's Medical Center Research Institute, University of Texas Southwestern Medical Center, Dallas, TX, 75390, USA.
Zhimin Gu *Children's Medical Center Research Institute, University of Texas Southwestern Medical Center, Dallas, TX, 75390, USA.
Hui CaoChildren's Medical Center Research Institute, University of Texas Southwestern Medical Center, Dallas, TX, 75390, USA.
Pranita KaphleChildren's Medical Center Research Institute, University of Texas Southwestern Medical Center, Dallas, TX, 75390, USA.
Junhua LyuChildren's Medical Center Research Institute, University of Texas Southwestern Medical Center, Dallas, TX, 75390, USA.
Yuannyu ZhangChildren's Medical Center Research Institute, University of Texas Southwestern Medical Center, Dallas, TX, 75390, USA.
Wenhuo HuHuman Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, NY, 10065, USA.ORCID 0000-0002-8686-7160
Stephen S ChungDivision of Hematology Oncology, Department of Internal Medicine, and Harold C. Simmons Comprehensive Cancer Center, University of Texas Southwestern Medical Center, Dallas, TX, 75390, USA.
Kathryn E DickersonChildren's Medical Center Research Institute, University of Texas Southwestern Medical Center, Dallas, TX, 75390, USA.
Jian XuChildren's Medical Center Research Institute, University of Texas Southwestern Medical Center, Dallas, TX, 75390, USA. jian.xu@utsouthwestern.edu.ORCID 0000-0003-1988-7337
Children's Medical Center · USMemorial Sloan Kettering Cancer Center · USThe University of Texas Southwestern Medical Center · US

Funding

X-RAY CRYSTALLOGRAPHYP30CA008748 · NCI · SLOAN-KETTERING INSTITUTE FOR CANCER RES · PI SELWYN M VICKERS · 1985 to 2026
$347.4M
Molecular Analysis of Transcriptional Enhancers in HematopoiesisR01DK111430 · NIDDK · UT SOUTHWESTERN MEDICAL CENTER · PI Jian Xu · 2016 to 2026
$4.8M
Targeting Metabolic Liabilities of Leukemia-Initiating Cells (R01CA230631)R01CA230631 · NCI · UT SOUTHWESTERN MEDICAL CENTER · PI XU, JIAN · 2019 to 2023
$1.8M
Elucidating the transcriptional mechanisms that control the expression of the SARS-CoV-2 receptor ACE2R21AI158240 · NIAID · UT SOUTHWESTERN MEDICAL CENTER · PI XU, JIAN · 2021 to 2021
$441k
NCI NIH HHS P30 CA008748NCI NIH HHS R01 CA230631NIAID NIH HHS R21 AI158240NIDDK NIH HHS R01 DK111430
6 · The paper itself

Abstract

Cancers develop from the accumulation of somatic mutations, yet it remains unclear how oncogenic lesions cooperate to drive cancer progression. Using a mouse model harboring NRas

Indexed as

Single-Cell AnalysisAnimalsApoptosisCarcinogenesisCell CycleEnhancer of Zeste Homolog 2 ProteinEpigenomicsGene Expression Regulation, NeoplasticGenetic HeterogeneityGTP PhosphohydrolasesHumansLeukemiaLeukemia, Myeloid, AcuteMembrane ProteinsMiceMice, KnockoutEnhancer of Zeste Homolog 2 ProteinEZH2 protein, humanGTP PhosphohydrolasesMembrane ProteinsNRAS protein, human

Identifiers

PMID34732703
PMCPMC8566485
OpenAlexW3210702954

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.